tranylcypromine sulfate

FDA Drug Profile — TRANYLCYPROMINE SULFATE, Tranylcypromine Sulfate, PARNATE

tranylcypromine sulfate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including TRANYLCYPROMINE SULFATE, Tranylcypromine Sulfate, PARNATE. Available dosage form: tablet, film coated.

Drug details

Generic Name
tranylcypromine sulfate
Brand Names
TRANYLCYPROMINE SULFATE, Tranylcypromine Sulfate, PARNATE
Application Number
ANDA040640
Sponsor
Strides Pharma Science Limited
NDC Codes
3
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
TRANYLCYPROMINE SULFATE

Indications and Usage

1 INDICATIONS & USAGE Tranylcypromine sulfate tablets are indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. Tranylcypromine sulfate tablets are not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [see Contraindications (4), Warnings and Precautions (5) , and Drug Interactions (7)]. Tranylcypromine sulfate tablets are a monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants ( 1 ) Tranylcypromine sulfate tablets are not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions ( 1 , 4 , 5 , 7 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.